Testing effectiveness (Phase 2)UnknownNCT03356444
What this trial is testing
Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate
Who this might be right for
Prostate CancerCastration-resistant Prostate CancerDrug
West China Hospital 140